Portfolio News

Matternet Set to Produce M2 Delivery Drones in the US After Receiving FAA Greenlight

Matternet’s groundbreaking FAA Type Certification for its M2 drone in September of 2022 was followed quickly by being granted a Production Certificate for the craft by the US Federal Aviation Administration. With the Production Certificate, Matternet can now begin mass production of its M2 drone at its factory in Mountain View, California. The Production Certificate will eventually allow Matternet to produce, test, and grant airworthiness certificates for M2 drones. To date, no other drone manufacturers have received the trio of certifications—Type, Production, and Airworthiness—that the FAA requires...

Running Through Walls: Thinking Long Term is the Greatest Gift

In a recent Venrock podcast, Aledade Founder and CEO Farzad Mostashari spoke about how to heighten the efficiency and effectiveness of patient care, specifically preventative care. He discusses how Aledade is working to help patients when average primary care practices can’t and the new launch of Aledade Care Solutions. He also shares his perspective on the strongest way to create a value-based care incentive structure. He starts the interview by discussing Aledade’s view of value-based care, which he defines as helping primary care practices make money...

Carrum Health, GRAIL strike up partnership to offer cancer test to employers

Cancer has managed to be the most expensive condition increasing employers’ costs. Seeing this issue as an opportunity to collaborate Carrum Health and GRAIL have teamed up to create a solution. Carrum Health is a value-based platform that helps employers and employees find easy access to Centers of Excellence. The collaboration will allow GRAIL’s Galleri early-detection cancer test to be offered as a benefit option to Carrum’s self-insured employers. Though musculoskeletal conditions were once the leading factor increasing employers’ healthcare costs, a recent survey by Business...

How The Healthcare Ecosystem Can Remove Barriers to Precision Health

CancerIQ CEO and Founder Feyi Ayodele recently shared some ideas about how to bring equity to precision health. “We are living in an era of tremendous progress against cancer,” Ayodele writes. Tools such as immunotherapy and multicancer early detection tests have given doctors the best tools to fight disease since the beginning of modern medicine. The problem is that long-standing disparities in cancer outcomes suggest that these tools could be applied more effectively. More than half a million people in the U.S. are projected to die from...

Patients With Alzheimer Disease Negatively Impacted by the COVID-19 Pandemic

In this interview, the second of a two-part series, Tabby Khan, MD, MPH, medical director at Komodo Health, discusses the effect the COVID-19 pandemic has had on patients with Alzheimer’s disease (AD). She also talks about how telehealth helped AD patients get care during the pandemic and about current research in the field. Komodo Health compared its research from 2020 and 2021 and saw an 18 percent increase in early-onset Alzheimer’s disease among patients between 45 and 65 years of age. Because Alzheimer’s diagnoses are rising...